Slope Clinical

Slope Clinical is a venture-backed, private company offering a specialized software-as-a-service (SaaS) platform for clinical trial biospecimen operations. Founded in 2019 by professionals with firsthand clinical operations experience, the company addresses a critical pain point in drug development: the inefficient and error-prone management of physical samples and associated data. Slope's platform has achieved significant independent adoption by over 2,200 clinical sites, including 83% of NCI-designated cancer centers, demonstrating strong product-market fit and a focus on empowering site staff. The company's value proposition centers on reducing sample-related waste and queries, thereby mitigating financial risk and accelerating study timelines for trial sponsors.

A unified cloud software platform that orchestrates the entire biospecimen lifecycle for clinical trials. It integrates inventory management, protocol execution guidance, sample tracking/chain of custody, and metadata orchestration to provide real-time visibility and control from lab kit logistics to final sample receipt.

Slope operates in a niche within the broader clinical trial management software market. It competes with generalized CTMS and EDC providers that may have basic sample tracking modules, as well as specialized sample management or logistics vendors. Its key differentiation is a unified, site-centric platform that addresses the entire biospecimen lifecycle with a focus on user experience and proactive error prevention.